Lacking these, such a score could also be used to assess the quantity of markers associated with processes associated with MetS-related risk, including adiponectin (which appears to be in the causative pathway of insulin resistance[20,48]) or markers of atherogenic dyslipidemia, including ApoB, small, dense LDL particles[49]. The gene discussed is APOB; the disease is Insulin resistance.